Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Wyeth Buys Mochida Pain Drug | Contract Pharma

What are you searching for?

Sign in
Breaking News

Wyeth Buys Mochida Pain Drug

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Wyeth has entered an agreement to purchase the global rights to develop and market an experimental pain medication from Mochida Pharmaceutical Co. Ltd., the Japanese company said on Wednesday. Financial terms were not disclosed.

The drug candidate, a new class of pain medications called TRPV1 antagonists, is in preclinical trials and is being developed to treat severe pain. Mochida will receive a one-time payment from Wyeth, as well as success-based development milestone payments. Mochida will retain the option of jointly developing and marketing the drug with Wyeth in Japan.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics